Novel therapeutic regimens against Helicobacter pylori: an updated systematic review

TT Huang, YX Cao, L Cao - Frontiers in Microbiology, 2024 - frontiersin.org
Helicobacter pylori (H. pylori) is a strict microaerophilic bacterial species that exists in the
stomach, and H. pylori infection is one of the most common chronic bacterial infections …

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance

Y Hu, Y Zhu, NH Lu - Frontiers in cellular and infection microbiology, 2017 - frontiersin.org
Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

Helicobacter pylori treatment: New perspectives using current experience

ATB Abadi - Journal of global antimicrobial resistance, 2017 - Elsevier
Infection with Helicobacter pylori plays an essential role in the development of duodenal and
gastric ulcers as well as in the pathobiology of gastric adenocarcinoma. Thus, successful …

[HTML][HTML] Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis

SP Zou, Q Cheng, CY Feng, C Xu… - World Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
BACKGROUND As a first-line treatment regimen for Helicobacter pylori (H. pylori) infection,
antibiotic therapy is widely used worldwide. However, the question of increasing antibiotic …

[PDF][PDF] Current status of H. pylori infection treatment 2017

B Paul, S Adimoolam, MJ Quereshi… - Journal of Applied …, 2017 - japsonline.com
H. pylori infection is highly associated with main symptoms and death that are recently
affecting 50-75% of the population in the world. But past few years' efforts, H. pylori treatment …

Helicobacter pylori infection

PI Hsu, Y Yamaoka, KL Goh, M Manfredi… - BioMed Research …, 2015 - go.gale.com
Helicobacter pylori (H. pylori) colonizes the gastric mucosa of more than 50% of the human
population. It is the major etiological agent of chronic gastritis, peptic ulcer, gastric mucosa …

Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies

IA Cardos, DC Zaha, RK Sindhu, S Cavalu - Molecules, 2021 - mdpi.com
The prevalence of Helicobacter pylori infection remains significant worldwide and it depends
on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All …

[HTML][HTML] Addressing Challenges in Standardizing Helicobacter pylori Treatment Protocols: Importance and Review

R Kaur, CL Guevara - Cureus, 2024 - ncbi.nlm.nih.gov
Helicobacter pylori, one of the top carcinogens, is associated with most cases of gastric
cancer-related deaths worldwide. Over the past two decades, the rising rates of antibiotic …

[HTML][HTML] Antibiotic treatment for Helicobacter pylori: Is the end coming?

SY Kim, DJ Choi, JW Chung - World journal of gastrointestinal …, 2015 - ncbi.nlm.nih.gov
Infection with the Gram-negative pathogen Helicobacter pylori (H. pylori) has been
associated with gastro-duodenal disease and the importance of H. pylori eradication is …

[HTML][HTML] Eradication of Helicobacter pylori infection: which regimen first?

A Federico, AG Gravina, A Miranda… - World journal of …, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a well-known human pathogen that plays an essential role
in the pathogenesis of chronic gastritis, peptic ulcer disease, and gastric malignancies …